The drug development landscape in Parkinson's
This event will be held in person. Please note slightly the later start time of 12:15pm
Originally a biochemist, Dr Kevin McFarthing’s career included R&D leadership positions in life sciences research products with Amersham, diagnostics with Serono and consumer healthcare with Reckitt Benckiser. He curates the Parkinson’s Hope List (bit.ly/ParkinsonsHopeList), a database of potential therapies in research and clinical stages. Kevin was diagnosed with Parkinson’s in 2012 at the age of 55.
Date:
24 May 2022, 12:15 (Tuesday, 5th week, Trinity 2022)
Venue:
Dorothy Crowfoot Hodgkin Building, off South Parks Road OX1 3QU
Venue Details:
This seminar will be held in the Dorothy Crowfoot Hodgkin Building (Phase II Biochemistry), Ground Floor Seminar Room (20-140). Email: opdc.administrator@dpag.ox.ac.uk for more details.
Speaker:
Dr Kevin McFarthing (Research Advisor, Parkinson’s UK Oxford Branch)
Organising department:
Department of Physiology, Anatomy and Genetics (DPAG)
Organiser:
Lorraine Dyson (University of Oxford)
Organiser contact email address:
opdc.administrator@dpag.ox.ac.uk
Host:
Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Part of:
OPDC Seminar Series (DPAG)
Booking required?:
Not required
Audience:
Members of the University only
Editors:
Samuel Press,
Lorraine Dyson
